Angiowave Imaging
About Angiowave Imaging
AngioWave Imaging is a healthcare AI company that develops post-processing medical AI technology to enhance the visualization of vascular structures during angiographic procedures. Their core product, AngioWaveNet, is FDA 510(k) cleared cardiac imaging AI software that integrates with existing fluoroscopic angiography systems. Unlike conventional noise-reduction or contrast filters, AngioWaveNet utilizes deep-learning-based spatiotemporal enhancement processing (STEP™) to interpret motion, structure, and time-based image data, revealing vessel details that may not be visible on unprocessed angiograms.
This technology is designed to aid cardiologists in diagnosing coronary artery disease more effectively by providing improved clarity imaging. The platform processes angiographic cines automatically after acquisition, offering enhanced images almost immediately, allowing clinicians to review both original and enhanced versions side-by-side without delaying procedures. This can lead to improved visualization of vessel structures, faster procedural decision-making, and increased confidence in navigating complex anatomy, particularly in challenging cases such as large patients (BMI > 40) and CTO patients. AngioWaveNet is compatible with standard DICOM formatted output from any imaging system in a cardiac catheterization laboratory and can also be applied retrospectively to previously acquired angiograms for re-analysis.
Focus Areas
Business Intelligence
| Technology | Cloud-based or on-premise/servers, DICOM endpoint for cardiac catheterization laboratory imaging systems, deep-learning based spatiotemporal enhancement processing (STEP™) |
What Physicians Need to Know
For physicians, Angiowave Imaging's AngioWaveNet™ offers enhanced visualization of coronary angiograms, which can be particularly beneficial in complex cases, such as those involving chronic total occlusions (CTOs) or large patients, where traditional imaging may be insufficient. The software integrates seamlessly into existing Cath lab workflows, providing enhanced images almost immediately for side-by-side review with original angiograms, without delaying procedures. It can also be used retrospectively for re-analysis, research, and education. Minimal training is required due to its intuitive design. It's important to note that AngioWaveNet-processed angiograms supplement the original unprocessed angiograms, which remain available, and all final clinical decisions should be made using the original unprocessed angiograms.
AngioWaveNet™ is designed to be compatible with standard DICOM formatted output from any imaging system vendor in a cardiac catheterization laboratory. It functions as a DICOM endpoint, receiving cines, processing them via its cloud platform (or on-premise servers), and returning enhanced DICOMs that can be viewed using any DICOM viewer and sent to a RIS/PACS for display.
What the Web Says
AngioWave Imaging is a healthcare AI company that has developed cardiac imaging AI software, AngioWaveNet, which is FDA 510(k) cleared. This software enhances fluoroscopic angiograms through advanced post-processing, providing improved vessel visualization and integrating directly into existing Cath lab workflows. Clinicians have reported improved visualization of vessel structures, faster procedural decision-making, and increased confidence in navigating complex anatomy, especially in challenging cases like those with high BMI or chronic total occlusions (CTO).
Overall: PositiveStrengths
- Improved visualization of vessel structures and details not visible on unprocessed angiograms.
- Faster procedural decision-making and increased confidence in navigating complex anatomy.
- Effective for challenging cases, including large patients (BMI > 40) and CTO patients.
- Integrates automatically into existing Cath lab workflows without delaying procedures.
- Can be used retrospectively on stored images for re-analysis, research, and education.
- Minimal training required due to intuitive software design.
Limitations
- No specific product or employer reviews were found on G2, Glassdoor, Capterra, or Reddit for Angiowave Imaging.
- Limited information available regarding company culture, salaries, or work-life balance from an employee perspective.
- One search result for "Wave Imaging Corporation" on Indeed showed very low ratings across all categories (work-life balance, pay and benefits, job security and advancement, management, and culture), but it is unclear if this is the same company as Angiowave Imaging.
Based on reviews from: AngioWave | AI Transforming Angiography (FAQ's), Spry Health - Physician Ai Tools, First Clinical Use of a Novel AI-Based Imaging Tool to Enhance CTO PCI Planning. - VIVO, accessdata.fda.gov (Angiowave Imaging, Inc. 510(k) Premarket Notification), AngioWave Artificial Intelligence-Assisted Analysis of Septal Collaterals for Retrograde Chronic Total Occlusion Percutaneous Coronary Intervention - PubMed, ENTITY: Type Startups in Concord | Startups Near Me, Indeed.com (Working at AngioDynamics), G2 (Best Radiology Information Systems), Ovid (Suspended Lead Suits and Radiation Exposure in...), Arteriosclerosis... (“A Time to Tear Down and a Time to Mend”: The...), Polygenic risk score for coronary artery disease across the spectrum ..., G2 (IntelePACS Reviews 2026: Details, Pricing, & Features), Indeed.com (Working at Wave Imaging Corporation)
Last updated: 2026-10-16
Videos
News, demos, and interviews about Angiowave Imaging.
Videos load interactively. If none appear, search YouTube for Angiowave Imaging →
Press & Coverage
Frequently Asked Questions
Comparisons
Related Companies
A2z Radiology AI is a Boston-based medical imaging AI company that develops software for comprehensive CT interpretation, initially focusing on abdomen-pelvis CT scans. The company’s primary goal is to enhance diagnostic accuracy and efficiency in medical imaging for healthcare providers by leveraging artificial intelligence. Their flagship product, a2z-Unified-Triage, is FDA-cleared radiological computer-aided triage and notification […]
Perimeter Medical Imaging AI is a medical technology company dedicated to transforming cancer surgery through the use of ultra-high-resolution, real-time, advanced imaging tools. The company’s mission is to address significant unmet medical needs in cancer surgery, particularly concerning positive margins and the resulting need for re-excisions. Their proprietary technology, including the S-Series Optical Coherence Tomography […]
SOPHiA GENETICS is a healthcare AI company that has developed a cloud-native, AI-driven SaaS platform called SOPHiA DDM™. This platform is designed to enable hospitals, clinical laboratories, academic medical centers, and biopharmaceutical companies to analyze and interpret complex genomic, radiomic, and multimodal healthcare data. The company’s mission is to democratize data-driven medicine, providing actionable insights […]
Qure.ai is a leading healthcare AI company that leverages deep learning and artificial intelligence to revolutionize medical imaging diagnostics and make healthcare more accessible and affordable globally. The company develops AI-powered solutions for interpreting X-rays and CT scans, addressing critical health needs in areas such as lung, musculoskeletal, cardiovascular, and neurocritical health. Their technology assists […]
Deep Bio is a healthcare AI company that develops deep learning-based cancer diagnostic support software, aiming to advance patient outcomes by empowering clinicians with innovative technology. Their mission is to provide tools that enable medical professionals to make critical decisions, ultimately enhancing healthcare delivery and allowing clinicians to focus more on patient care. The company’s […]
CortiCare is a healthcare AI company specializing in neuro telemetry and remote patient monitoring, primarily focusing on electroencephalogram (EEG) services. The company provides telehealth services and an EEG brain monitoring platform to neurology and critical care areas within hospitals, including ICUs, NICUs, PICUs, and EMUs. Their services aim to enhance the neurological assessment of adult, […]